A tRNA-derived fragment of ginseng protects heart against ischemia/reperfusion injury via targeting the lncRNA MIAT/VEGFA pathway

Traditional Chinese medicines (TCMs) have been widely used for treating ischemic heart disease (IHD), and secondary metabolites are generally regarded as their pharmacologically active components. However, the effects of nucleic acids in TCMs remain unclear. We reported for the first time that a 22-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Kua, Yan, Tong-Meng, Cao, Kai-Yue, Li, Fang, Ma, Xiao-Rong, Lai, Qiong, Liu, Jin-Cheng, Pan, Yu, Kou, Jun-Ping, Jiang, Zhi-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440274/
https://www.ncbi.nlm.nih.gov/pubmed/36090756
http://dx.doi.org/10.1016/j.omtn.2022.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440274/
https://www.ncbi.nlm.nih.gov/pubmed/36090756
http://dx.doi.org/10.1016/j.omtn.2022.08.014

Ejemplares similares